Tag:
Merck KGaA
Latest Headlines
Latest Headlines
Merck KGaA says cuts will save $385 million
Merck KGaA today put euro signs to the restructuring it announced last month, which includes some cuts to its manufacturing division.
German Merck tracking drugs in Africa with texts
A startup company has taken aim at drug counterfeiting in developing countries with a technology that relies on cell phones and what it refers to on its website as "crowd-sourced pharmacovigilance."
Merck KGaA manufacturing dodges worst of reductions
The company is closing its Merck Serono headquarters in Geneva, Switzerland, and will eliminate 500 positions and transfer another 750 to locations around the world.
Updated: Virtual MS research community emerges
Stakeholders in the development of multiple sclerosis drugs have taken their fight against the neurodegenerative disease online with the launch of a virtual community.
FSP outsourcing approach remains in demand
Big pharma companies remain interested in the functional service provider model for outsourcing, and CROs are trying to respond in kind.
Ventria forges supply pact with Merck KGaA
Ventria Bioscience has scored a supply deal with Merck KGaA.
UPDATED: FDA inspects three Merck KGaA plants along EU supply chain
The FDA found problems at three Merck KGaA API and drug manufacturing facilities along a single supply chain in Europe last summer from which ingredients were fed to a plant in Germany. It is unusual...
Oncothyreon awaits pivotal data on Stimuvax
Oncothyreon ($ONTY) execs are expecting interim results from a late-stage study of lung cancer vaccine Stimuvax sometime this quarter. Results from the 1,514-person trial, which is being conducted by...
Keeping FLEXible, EGFR predicts lung cancer survival
Patients with advanced non-small-cell lung cancer (NSCLC), the most common form of lung cancer, don't have many options for treatment and tend not to have a long life expectancy. According to results
Yates to head EMD Millipore
EMD Millipore, a unit of Merck KGaA, has tapped Robert Yates as its president, effective Sept. 1. He previously was a member of the Roche diagnostics division, where he led the life science business
